Charles Mesguich

562 total citations
18 papers, 326 citations indexed

About

Charles Mesguich is a scholar working on Hematology, Surgery and Molecular Biology. According to data from OpenAlex, Charles Mesguich has authored 18 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Charles Mesguich's work include Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Protein Degradation and Inhibitors (4 papers). Charles Mesguich is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Protein Degradation and Inhibitors (4 papers). Charles Mesguich collaborates with scholars based in France and United States. Charles Mesguich's co-authors include Laurence Bordenave, Elif Hindié, Gérald Marit, Lawrence Tanenbaum, Sundar Jagannath, Ajai Chari, Lale Kostakoğlu, Cyrille Hulin, Antoine Tabarin and Virginie Grouthier and has published in prestigious journals such as British Journal of Haematology, Journal of Nuclear Medicine and Clinical Endocrinology.

In The Last Decade

Charles Mesguich

17 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Mesguich France 9 119 102 85 64 62 18 326
Xiaofang Li China 10 88 0.7× 71 0.7× 35 0.4× 13 0.2× 44 0.7× 32 317
Andrea Tedeschi Italy 9 42 0.4× 68 0.7× 46 0.5× 38 0.6× 7 0.1× 22 264
Anita Paisant France 13 107 0.9× 63 0.6× 19 0.2× 76 1.2× 216 3.5× 46 417
B Gallet France 10 100 0.8× 42 0.4× 49 0.6× 25 0.4× 102 1.6× 33 393
Takahiro Jimbo Japan 12 229 1.9× 78 0.8× 46 0.5× 12 0.2× 13 0.2× 46 396
Cosimo Lequaglie Italy 13 151 1.3× 32 0.3× 162 1.9× 30 0.5× 67 1.1× 43 480
Gerhard Kalweit Germany 13 152 1.3× 16 0.2× 68 0.8× 36 0.6× 45 0.7× 31 422
Ariela Arad Israel 8 28 0.2× 105 1.0× 28 0.3× 28 0.4× 22 0.4× 21 338
Julie Guest United States 5 111 0.9× 48 0.5× 25 0.3× 14 0.2× 21 0.3× 8 291
Bassam Redwan Germany 11 149 1.3× 73 0.7× 25 0.3× 20 0.3× 26 0.4× 42 563

Countries citing papers authored by Charles Mesguich

Since Specialization
Citations

This map shows the geographic impact of Charles Mesguich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Mesguich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Mesguich more than expected).

Fields of papers citing papers by Charles Mesguich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Mesguich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Mesguich. The network helps show where Charles Mesguich may publish in the future.

Co-authorship network of co-authors of Charles Mesguich

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Mesguich. A scholar is included among the top collaborators of Charles Mesguich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Mesguich. Charles Mesguich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rivière, Étienne, et al.. (2025). Sarcoid ichthyosis with tiger-man sign: a new ‘tigerfish’ syndrome in sarcoidosis?. QJM. 118(6). 463–465.
2.
Mesguich, Charles, et al.. (2024). Course of immune thrombocytopenia according to the site of platelet destruction identified by indium‐111 platelet scintigraphy. British Journal of Haematology. 206(1). 279–289. 1 indexed citations
3.
Mesguich, Charles, et al.. (2023). Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 67(2). 114–121. 4 indexed citations
4.
Mesguich, Charles, et al.. (2022). 18F-FDG PET/CT and MRI in the Management of Multiple Myeloma: A Comparative Review. PubMed. 1. 808627–808627. 7 indexed citations
5.
Galtier, Jean, Laëtitia Vercellino, Loïc Chartier, et al.. (2022). Positron emission tomography-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T cells. Haematologica. 108(1). 171–180. 19 indexed citations
6.
7.
Mesguich, Charles, Elif Hindié, Baudouin Denis de Senneville, et al.. (2021). Improved 18-FDG PET/CT diagnosis of multiple myeloma diffuse disease by radiomics analysis. Nuclear Medicine Communications. 42(10). 1135–1143. 18 indexed citations
8.
Mesguich, Charles, Cyrille Hulin, V. Latrabe, et al.. (2020). Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma. Annals of Hematology. 99(12). 2869–2880. 21 indexed citations
9.
10.
Mesguich, Charles, et al.. (2020). Choline PET/CT in Multiple Myeloma. Cancers. 12(6). 1394–1394. 13 indexed citations
11.
12.
Mesguich, Charles, Karine Nubret, Fabrice Camou, et al.. (2018). Infections in patients using ventricular-assist devices: Comparison of the diagnostic performance of 18F-FDG PET/CT scan and leucocyte-labeled scintigraphy. Journal of Nuclear Cardiology. 26(1). 42–55. 42 indexed citations
13.
Grouthier, Virginie, Nadia Mehsen-Cêtre, Renaud Winzenrieth, et al.. (2018). Assessment of vertebral microarchitecture in overt and mild Cushing's syndrome using trabecular bone score. Clinical Endocrinology. 89(2). 148–154. 60 indexed citations
14.
Pinaquy, Jean‐Baptiste, et al.. (2017). Role of 18F-FDG PET/CT in Posttreatment Evaluation of Anal Carcinoma. Journal of Nuclear Medicine. 58(9). 1414–1420. 22 indexed citations
15.
Mesguich, Charles, Krimo Bouabdallah, Pierre Soubeyran, et al.. (2016). Hodgkin lymphoma: a negative interim‐PET cannot circumvent the need for end‐of‐treatment‐PET evaluation. British Journal of Haematology. 175(4). 652–660. 8 indexed citations
16.
Mesguich, Charles, et al.. (2016). The impact of combination of regadenoson and isometric exercise on image quality of myocardial perfusion scintigraphy. Journal of Nuclear Cardiology. 24(3). 993–997. 2 indexed citations
17.
Mesguich, Charles, et al.. (2015). High performances of 18F-fluorodeoxyglucose PET-CT in cardiac implantable device infections: A study of 40 patients. Journal of Nuclear Cardiology. 22(4). 787–798. 44 indexed citations
18.
Mesguich, Charles, et al.. (2014). State of the art imaging of multiple myeloma: Comparative review of FDG PET/CT imaging in various clinical settings. European Journal of Radiology. 83(12). 2203–2223. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofang Li Breakdown of academic impact, for papers by Andrea Tedeschi Breakdown of academic impact, for papers by Anita Paisant Breakdown of academic impact, for papers by B Gallet Breakdown of academic impact, for papers by Takahiro Jimbo Breakdown of academic impact, for papers by Cosimo Lequaglie Breakdown of academic impact, for papers by Gerhard Kalweit Breakdown of academic impact, for papers by Ariela Arad Breakdown of academic impact, for papers by Julie Guest Breakdown of academic impact, for papers by Bassam Redwan
Rankless by CCL
2026